Interactive Investor
>>

Diurnal Group (LSE:DNL) Share Price

DNL

Diurnal Group

UK company

Right Arrow 1

Healthcare

Right Arrow 2

Drug Manufacturers - Specialty & Generic

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XLON

-

Updated: -

Research

News & analysis

Regulatory news

Loading...

Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Diurnal Group PLC is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism, and Hypothyroidism. The company has two products in late-stage clinical development targeting Adrenal diseases; Chronocort to be used for the treatment of Congenital Adrenal Hyperplasia and Adrenal Insufficiency in Adults and Infacort which is to be used for the same conditions in children. Its main country of operation is the United Kingdom.Diurnal Group PLC is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.

LSE:DNL

GB00BDB6Q760

GBX

Loading...

Loading Comparison

Latest DNL News

DNL Regulatory News